Balchem Corporation logo

Balchem Corporation (BL9B)

Market Closed
15 Jul, 07:32
XDUS XDUS
138. 00
-2.5
-1.7794%
- Market Cap
44.02 P/E Ratio
0.79% Div Yield
0 Volume
4.27 Eps
140.5
Previous Close
Add Transaction
Day Range
138 138.4
Year Range
120.2 156.1
Want to track BL9B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BL9B closed Wednesday lower at €138, a decrease of -1.7794% from Tuesday's close, completing a monthly decrease of -4.8276% or -€7. Over the past 12 months, BL9B stock gained 7.8968%.
BL9B pays dividends to its shareholders, with the most recent payment made on Jan 20, 2026. The next estimated payment will be in In 6 months on Jan 20, 2027 for a total of €0.96.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.43%, based on the last three reports.
Balchem Corporation has completed 8 stock splits, with the recent split occurring on Jan 21, 2010.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

BL9B Chart

Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript

Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript

Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings

Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings

The Conestoga SMid Cap Composite returned -10.24% net-of-fees in the first quarter, lagging the Russell 2500 Growth Index's return of -3.52%. RBC's performance was driven by continued strength in aerospace and defense, where demand remains robust and increasingly visible through a growing backlog. Despite a solid quarter, Repligen stock underperformed as investors focused on a more measured outlook and lingering concerns around end-market demand.

Seekingalpha | 2 months ago
Balchem: An Attractive Valuation Makes This Stock A Buy

Balchem: An Attractive Valuation Makes This Stock A Buy

Balchem delivered strong Q4 results, with revenue up nearly 10% year-over-year and all segments posting growth. BCPC boasts a 17-year streak of double-digit dividend hikes, supported by a payout ratio consistently below 20%. The stock trades at a roughly 25% discount to its estimated fair value, with robust forward return potential exceeding 14%.

Seekingalpha | 3 months ago

Balchem Corporation (BL9B) FAQ

What is the stock price today?

The current price is €138.00.

On which exchange is it traded?

Balchem Corporation is listed on XDUS.

What is its stock symbol?

The ticker symbol is BL9B.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.79%.

What is its market cap?

As of today, no market cap data is available.

Has Balchem Corporation ever had a stock split?

Balchem Corporation had 8 splits and the recent split was on Jan 21, 2010.

Balchem Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
Theodore L. Harris CEO
XDUS Exchange
US0576652004 ISIN
US Country
1,368 Employees
23 Dec 2025 Last Dividend
21 Jan 2010 Last Split
3 Jun 1986 IPO Date

Overview

Balchem Corporation is a leading company in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to a diverse range of industries globally. Since its inception in 1967, Balchem has been dedicated to serving the nutritional, food, pharmaceutical, animal health, plant nutrition, industrial markets, and medical device sterilization. The company operates through three business segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, ensuring a comprehensive approach to innovation and customer service. With its headquarters in Montvale, New Jersey, Balchem aims to leverage its extensive expertise to advance health, nutrition, and safety across various applications worldwide.

Products and Services

Balchem Corporation offers a wide variety of products and services across its diversified segments:

  • Human Nutrition & Health: This segment focuses on supplying ingredients to the food and beverage industry. Among its offerings are:
    • Spray dried and emulsified powders, designed for various food applications.
    • Extrusion and agglomeration technologies for improved ingredient delivery.
    • Blended lipid systems and liquid flavor delivery systems for enhanced food quality.
    • Juice and dairy bases, chocolate systems, cereal systems, ice cream bases, and variegates to enrich consumer products.
    • Specialty vitamin K2 and microencapsulation solutions targeting health and nutrition applications.
    • Human grade choline nutrients and mineral amino acid chelated products aimed at optimizing nutrition and health.
  • Animal Nutrition & Health: This segment delivers solutions aimed at improving the health and production of animals, including:
    • Microencapsulated products designed to enhance health and milk production in ruminant animals.
    • Chelation technology that offers enhanced nutrient absorption for various animal species.
    • Methylsulfonylmethane (MSM) for dietary supplements.
    • Choline chloride, serving as a vital nutrient for monogastric animal health.
  • Specialty Products: This segment focuses on products for more specialized markets, such as healthcare and agriculture, offering:
    • Ethylene oxide and ammonia for the healthcare industry, specifically for device sterilization.
    • Single use canisters for sterilizing reusable medical devices.
    • Propylene oxide as a fumigant to control insects and microbiological spoilage in food products like nuts, spices, and dried fruits.
    • Chelated minerals for enhancing the growth of high-value crops.

Balchem sells its diverse range of products through a combination of its sales force, independent distributors, and sales agents, ensuring a broad reach and efficient delivery to its global customer base.

Contact Information

Address: 5 Paragon Drive
Phone: 845 326 5600